skip to Main Content
Founded in 1946

Register Now! 2021 CME Webinar Coming Soon!

$75.00$155.00

REGISTRATION IS NOW OPEN!

The Oklahoma Psychiatric Physicians Association
announces its annual CME Conference
will be presented as a live virtual program
on the ZOOM Webinar Platform.

FRIDAY, NOVEMBER 5, 2021; 3:13 pm – 6:30 pm
SATURDAY, NOVEMBER 6, 2021; 8:00 am – 5:15 pm

“Multiple Frontiers for Innovative Post-Pandemic Psychiatry

 

The American Psychiatric Association designates this live activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychiatric residents may participate in this webinar at no cost. Psychiatric residents may register by sending their name, school affiliation, PGY year and email address to oklapsychiatry@gmail.com.

Registration fee for all current OPPA members is $150. Non-OPPA member psychiatrists and other physicians are welcome to attend for a $155 registration fee. Other healthcare professionals (PA, NP, RN, PhD, MSW) for a $75 fee.

Clear

SKU: N/A Category:

Description

Course Description

Beginning in March 2020, our world as practicing psychiatrists changed. This 2021 Annual CME program of the Oklahoma Psychiatric Physicians Association will offer a unique educational experience and serve as a harbinger of the future of mid- 21st Century psychiatry.

The COVID-19 pandemic changed medical school education and psychiatric residency training. New onset psychosis resulting from COVID infection and other longstanding psychiatric sequelae of COVID infection, including the multiple stressors of isolation and economic devastation has resulted in the exponential increase in the use and abuse of methamphetamine and marijuana. Telemedicine treatment interventions for psychiatrists are increasingly common as are emerging new treatments such as Integrative Functional Medicine and infusion treatments for patients with depression and postpartum depression who are resistant to traditional psychopharmacology. An update on the opioid epidemic, which has yet taken a worse turn in Oklahoma, will be provided. (Attending this program will meet the requirement of the Oklahoma Medical Board of Licensure and Supervision.)

Research and clinical presentations by residents in Oklahoma’s Residency training programs promote the good feeling that the psychiatric profession is well-prepared to meet future challenges.

Learning Objectives

  • Consider the impact of the COVID-19 Pandemic on medical and psychiatric education, and the effect of patient care and outcomes.
  • Analyze newer treatment modalities of Ketamine and Esketamine via Intravenous infusion and via nasal spray for treatment resistant depressions, and Infusion treatment for post-partum depression.
  • Evaluate how psychiatric practitioners can contribute to prevention of unnecessary opiate overdose related deaths.
  • Determine a strategy for long-term professional success of psychiatrists despite intrusion by mid-level mental health professionals.

Target Audience

This program was developed for Oklahoma psychiatric physicians to learn how to adapt to meet the new challenges of a post-pandemic health care environment.

 

 

 

Additional information

Registration Type

OPPA Member, Non-OPPA Member, Other: PA, NP, RN, PhD, MSW

Back To Top